Table 3.
Characteristics of Case Probands and Their Qualifying (First) Primary Invasive Melanoma by Study Center, and Comparison With All Melanomas Identified in the Same Region and for the Same Age Group at the Population-based Cancer Registries, Australian Melanoma Family Study, 2001–2005a
Brisbane |
Sydney |
Melbourne |
Total | |||||||||||
AMFS |
Registry, %b | P Valuec | AMFS |
Registry, %b | P Valuec | AMFS |
Registry, %b | P Valuec | AMFS |
|||||
No. | % | No. | % | No. | % | No. | % | |||||||
Total, cases | 234 | 169 | 226 | 629 | ||||||||||
Sex | ||||||||||||||
Male | 99 | 42.3 | 45.8 | 71 | 42.0 | 48.3 | 73 | 32.3 | 40.5 | 243 | 38.6 | |||
Female | 135 | 57.7 | 54.2 | 0.45 | 98 | 58.0 | 51.7 | 0.16 | 153 | 67.7 | 59.5 | 0.04 | 386 | 61.4 |
Age at diagnosis, years | ||||||||||||||
Median | 33.1 | 32 | 32.7 | 32 | 33.3 | 32 | 32.9 | |||||||
18–24 | 40 | 17.1 | 13.4 | 13 | 7.7 | 11.8 | 25 | 11.1 | 14.8 | 78 | 12.4 | |||
25–29 | 41 | 17.5 | 24.4 | 33 | 19.5 | 19.8 | 49 | 21.7 | 20.0 | 123 | 19.6 | |||
30–34 | 67 | 28.6 | 21.8 | 60 | 35.5 | 33.0 | 64 | 28.3 | 29.2 | 191 | 30.4 | |||
35–39 | 86 | 36.8 | 40.3 | 0.10 | 63 | 37.3 | 35.4 | 0.51 | 88 | 38.9 | 36.0 | 0.53 | 237 | 37.7 |
Country of birth | ||||||||||||||
Australia | 208 | 88.9 | 85.9 | 137 | 81.5 | 84.5 | 198 | 87.6 | 89.2 | 543 | 86.5 | |||
New Zealand | 9 | 3.8 | 6.3 | 8 | 4.8 | 2.5 | 4 | 1.8 | 1.5 | 21 | 3.3 | |||
United Kingdom, Ireland | 9 | 3.8 | 5.5 | 12 | 7.1 | 4.7 | 10 | 4.4 | 4.4 | 31 | 4.9 | |||
Other | 8 | 3.4 | 2.3 | 0.58 | 11 | 6.5 | 8.2 | 0.35 | 14 | 6.2 | 4.9 | 0.94 | 33 | 5.3 |
Unknown | 0 | 1 | 0 | 1 | ||||||||||
Breslow thickness, mm | ||||||||||||||
Median | 0.50 | 0.50 | 0.65 | 0.60 | 0.60 | 0.55 | ||||||||
0.01–1.00 | 195 | 83.3 | 86.2 | 125 | 74.4 | 75.3 | 185 | 82.6 | 80.1 | 505 | 80.7 | |||
1.01–2.00 | 31 | 13.2 | 10.3 | 29 | 17.3 | 15.3 | 23 | 10.3 | 10.9 | 83 | 13.3 | |||
2.01–4.00 | 6 | 2.6 | 3.4 | 6 | 3.6 | 6.2 | 10 | 4.5 | 5.6 | 22 | 3.5 | |||
>4.00 | 2 | 0.9 | 0.1 | 0.67 | 8 | 4.8 | 3.1 | 0.42 | 6 | 2.7 | 3.4 | 0.86 | 16 | 2.6 |
Unspecified | 0 | 1 | 2 | 3 | ||||||||||
Anatomic site | ||||||||||||||
Face, ears | 15 | 6.5 | 4.3 | 12 | 7.1 | 6.6 | 16 | 7.1 | 6.7 | 43 | 6.9 | |||
Neck, scalp | 12 | 5.2 | 6.5 | 15 | 8.9 | 6.6 | 15 | 6.7 | 5.4 | 42 | 6.7 | |||
Trunk | 92 | 39.8 | 37.9 | 52 | 30.8 | 37.8 | 72 | 32.1 | 35.6 | 216 | 34.6 | |||
Upper limb including shoulder | 55 | 23.8 | 19.8 | 32 | 18.9 | 20.7 | 47 | 21.0 | 20.8 | 134 | 21.5 | |||
Lower limb including hip | 57 | 24.7 | 31.5 | 0.38 | 58 | 34.3 | 28.3 | 0.35 | 74 | 33.0 | 31.5 | 0.90 | 189 | 30.3 |
Unspecified | 3 | 0 | 2 | 5 | ||||||||||
Histology | ||||||||||||||
Superficial spreading | 163 | 69.7 | 75.2 | 74 | 43.8 | 54.2 | 123 | 54.4 | 0.0 | 360 | 57.2 | |||
Not otherwise specified | 52 | 22.2 | 18.9 | 87 | 51.5 | 35.6 | 84 | 37.2 | 92.6d | 223 | 35.5 | |||
Nodular | 14 | 6.0 | 4.2 | 3 | 1.8 | 6.9 | 12 | 5.3 | 0.0 | 29 | 4.6 | |||
Other subtypese | 5 | 2.1 | 1.7 | 0.56 | 5 | 3.0 | 3.3 | 0.001 | 7 | 3.1 | 7.4 | <0.001 | 17 | 2.7 |
Index of relative socioeconomic disadvantage, quintilesf | ||||||||||||||
1 (most disadvantage) | 12 | 5.2 | 6.3 | 7 | 4.3 | 11.4 | 22 | 10.1 | 41 | 6.7 | ||||
2 | 53 | 23.1 | 16.0 | 23 | 14.3 | 7.5 | 56 | 25.7 | 132 | 21.7 | ||||
3 | 78 | 34.1 | 18.9 | 29 | 18.0 | 7.3 | 53 | 24.3 | 160 | 26.3 | ||||
4 | 44 | 19.2 | 27.7 | 48 | 29.8 | 33.0 | 41 | 18.8 | 133 | 21.9 | ||||
5 (least disadvantage) | 42 | 18.3 | 31.0 | <0.001 | 54 | 33.5 | 40.7 | <0.001 | 46 | 21.1 | 142 | 23.4 |
Abbreviations: AMFS, Australian Melanoma Family Study; SEIFA, Socioeconomic Indexes for Areas.
Missing or unknown data are excluded from percentage calculations.
These data were obtained from the population-based cancer registries and represent all subjects from the Brisbane, Sydney, and Melbourne metropolitan regions, respectively, who were diagnosed with primary invasive melanoma during the study accrual period (from July 1, 2000, to December 31, 2002) and in the same age group (aged 18–39 years at the time of diagnosis).
χ2 test for association comparing the distribution of melanoma risk factors between AMFS subjects and individuals identified by the cancer registry and excluding missing/unknown data. P values are 2 sided.
During this period, the Victorian cancer registry did not code the histology of all melanoma subtypes, so, apart from some of the rarer morphologies, most melanomas including “superficial spreading” and most “nodular” were coded to “not otherwise specified.”
Other histologic subtypes (total number of AMFS cases) include the following: malignant melanoma, regressing (n = 9); lentigo maligna melanoma (n = 3); acral lentiginous melanoma (n = 3); and desmoplastic melanoma (n = 2).
Based on 2001 SEIFA data published by the Australian Bureau of Statistics (www.abs.gov.au), by use of state-wide quintiles. The Index ranks areas on the level of social and economic well-being based on area of residence. SEIFA data were not available from the Victorian cancer registry for Melbourne.